Target intelligence / Profile preview

MON2 regulator of endosome-to-Golgi trafficking (MON2)

Target
MON2
Molecular classification
Other (Scaffold/regulatory protein involved in vesicular trafficking)
01

Overview

MON2 regulator of endosome-to-Golgi trafficking (MON2) is a conserved scaffold protein essential for proper vesicular transport between endosomes and the Golgi apparatus. MON2 localizes primarily to the trans-Golgi network and recycling endosomes[1][2]. Depletion of MON2 in mammalian cells accelerates the retrograde trafficking of transmembrane proteins such as furin and cation-independent mannose 6-phosphate receptor, suggesting it suppresses endosome-to-Golgi delivery under normal conditions[1]. In yeast, MON2 regulates retrograde transport, endocytosis, and vacuole biogenesis, interacting with proteins such as Dop1, Neo1, and GGA1. MON2 is required for the upregulation of autophagy, particularly under cellular stress (e.g., starvation), enhancing autophagosome formation via interaction with GABARAPL2[2][3]. Its role is implicated in the regulation of longevity in organisms, including *C. elegans*, by mediating trafficking and proper localization of autophagy factors, but no drugs, clinical biomarkers, or direct disease roles are currently established for MON2 in human medicine[2][3][4].

Other names
Protein MON2 homologKIAA1040SF21MON2 homologregulator of endosome-to-Golgi traffickingprotein SF21
02

Biological functions

Protein transportGolgi to endosome transportEndosome-to-Golgi retrograde traffickingRegulation of autophagosome formation and autophagy
03

Disease associations

Other (Research links modulation of MON2 function to cellular processes relevant to aging and longevity; however, no direct role in major human diseases such as cancer or neurodegeneration is established)

Beyond the preview

Go deeper on MON2 regulator of endosome-to-Golgi trafficking (MON2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MON2 regulator of endosome-to-Golgi trafficking (MON2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call